Executive Director, Therapeutic Area Strategy, Oncology and Hematology

Brings external benchmarking, analysis and insights, and judgement to support the TA Strategy Head in developing a holistic Novartis TA strategy that achieves sustainable growth in short, mid and long-term. Brings both understanding of the pharmaceutical industry and the core Therapeutic Areas (TA) and Disease area of Oncology & Hematology to derive insightful and differentiating competitive advantages over our peers. Provides key commercial insights to the R&D; project teams, particularly for early phase programs. To do this effectively, in-market experience in the US is critical. Analyses reports and publications to extract key messages, including building product forecasts. Supports development and delivery of TA-specific strategic external insights to support identification of growth opportunities, emerging competitive challenges and support creation of a third-party view around key strategic levers, and commissions targeted primary research.

The Novartis Strategy & Growth, Therapeutic Area Strategy team for Oncology & Hematology is seeking a new Executive Director, Therapeutic Area Strategy who will support the creation and update of a holistic TA strategy; provide early-phase commercial insights to project teams; guide TA-specific internal pipeline development and external licensing / acquisitions opportunities; and support integrated enterprise alignment across Biomedical Research (BR), Development, Strategy & Growth (S&G;), and the Commercial US and International units.

• Bachelor's degree required. Advanced degree (PhD, MD or other advanced University degree) and / or equivalent experience in life science/healthcare; MBA or consulting or equivalent experience highly preferred.

• In-depth TA knowledge (or track record to acquire required TA expertise effectively and rapidly) in Oncology and/or Hematology.

• Highly agile having the capacity to support a number of strategic DAs within a TA and multiple programs internal and external

• Substantial experience evaluating new product opportunities (through M&A;, BD&L; and internal re-search programs).

• 7-10 years of Industry pharma and/or medical devices Experience in Research & Development and/or commercial functions with experience conducting, commissioning, analyzing primary research

• Experience of strategy development and asset shaping early in lifecycle (any functional perspective)

• Recent (post 2015) local US in-market experience; local US experience includes working within the US market with the local US customers, US health care systems / systems